Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Roser, James D ^a   Chertova, Elena ^a   Smedley, Jeremy ^a,b   Gregory Alvord, W ^a   Del Prete, Gregory Q ^a   Estes, Jacob D ^a   Lifson, Jeffrey D ^a   Keele, Brandon F ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Evolution; Models of AIDS; SIV

Indexed keywords

NUCLEOTIDE; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CLONE; CONTROLLED STUDY; NONHUMAN; POINT MUTATION; REVERTANT; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SITE DIRECTED MUTAGENESIS; VIREMIA; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION;

PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84931266391     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0175-3     Document Type: Article

References (28)

1. Alexander L, Denekamp L, Czajak S, Desrosiers RC (2001) Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239. J Virol 75(8):4019-4022. doi: 10.1128/Jvi.75.8.4019-4022.2001
2. Das AT, Klaver B, Berkhout B (1995) Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol 69(5):3090-3097
3. Das AT, Klaver B, Berkhout B (1997) Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA(Lys) molecule in reverse transcription. J Gen Virol 78(Pt 4):837-840
4. Raba M, Limburg K, Burghagen M, Katze JR, Simsek M, Heckman JE et al (1979) Nucleotide sequence of three isoaccepting lysine tRNAs from rabbit liver and SV40-transformed mouse fibroblasts. Eur J Biochem/FEBS 97(1):305-318
5. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B et al (1993) Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 67(6):3246-3253
6. Soderberg K, Denekamp L, Nikiforow S, Sautter K, Desrosiers RC, Alexander L (2002) A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase. J Virol 76(11):5803-5806. doi: 10.1128/Jvi.76.11.5803-5806.2002
7. Kestler HW 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD et al (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65(4):651-662
8. Kati WM, Johnson KA, Jerva LF, Anderson KS (1992) Mechanism and fidelity of HIV reverse-transcriptase. J Biol Chem 267(36):25988-25997
9. Preston BD, Poiesz BJ, Loeb LA (1988) Fidelity of HIV-1 reverse-transcriptase. Science 242(4882):1168-1171. doi: 10.1126/Science.2460924
10. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH et al (2009) Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 83(8):3556-3567. doi: 10.1128/JVI.02132-08
11. Baalwa J, Wang SY, Parrish NF, Decker JM, Keele BF, Learn GH et al (2013) Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology 436(1):33-48. doi: 10.1016/J.Virol.2012.10.009
12. Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E et al (2009) Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. doi: 10.1371/Journal.Ppat.1000274
13. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG et al (2008) Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 105(21):7552-7557. doi: 10.1073/Pnas.0802203105
14. Li H, Bar KJ, Wang SY, Decker JM, Chen YL, Sun CX et al (2010) High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. doi: 10.1371/Journal.Ppat.1000890
15. Novitsky V, Wang R, Margolin L, Baca J, Rossenkhan R, Moyo S et al (2011) Transmission of single and multiple viral variants in primary HIV-1 subtype C infection. PLoS One. doi: 10.1371/journal.pone.0016714
16. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H et al (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206(6):1273-1289. doi: 10.1084/Jem.20090378
17. Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T et al (2009) Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 206(5):1117-1134. doi: 10.1084/Jem.20082831
18. Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A et al (2010) Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 84(19):10406-10412. doi: 10.1128/Jvi.01155-10
19. Ma ZM, Keele BF, Qureshi H, Stone M, Desilva V, Fritts L et al (2011) SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. AIDS Res Hum Retrovir 27(12):1259-1269. doi: 10.1089/aid.2011.0090
20. Stone M, Keele BF, Ma ZM, Bailes E, Dutra J, Hahn BH et al (2010) A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J Virol 84(14):7083-7095. doi: 10.1128/JVI.00481-10
21. Del Prete GQ, Park H, Fennessey CM, Reid C, Lipkey L, Newman L et al (2014) Molecularly tagged SIVmac239 synthetic swarm for tracking independent infection events. J Virol. doi: 10.1128/JVI.01026-14
22. Han JH, Harding JD (1983) Using iodinated single-stranded M13 probes to facilitate rapid DNA sequence analysis--nucleotide sequence of a mouse lysine tRNA gene. Nucleic Acids Res 11(7):2053-2064
23. Fennessey CM, Keele BF (2013) Using nonhuman primates to model HIV transmission. Curr Opin HIV AIDS 8(4):280-287. doi: 10.1097/Coh.0b013e328361cfff
24. Hirsch VM, Lifson JD (2000) Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 49:437-477
25. Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, Pollara J et al (2013) Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol 87(6):3538-3548. doi: 10.1128/JVI.02863-12
26. 2+ from nucleocapsid protein. Virology 375(1):148-158. doi: 10.1016/J.Virol.2008.01.045
27. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T et al (2007) Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 81(16):8827-8832. doi: 10.1128/Jvi.00895-07
28. Cline AN, Bess JW, Piatak M, Lifson JD (2005) Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 34(5-6):303-312